Other

Abbott Laboratories Corporation

Nicholas Plotnikoff

Noreen Griffin

Fengping Shan

Harold Elmer Zaugg

Cheuk M Lee

Raymond John Michaels

A method for inducing a sustained immune response in humans or animal patient suffering from human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS, autoimmune disease, cancer, inflammation, and neurodegenerative diseases comprises daily administration to such patients a single oral tablet, rapidly dissolving film, capsule, liquid or cream dose of an Immediate release naltrexone composition comprising between about 0.01 to about 10 mg of naltrexone. In order to provide a benefit the naltrexone must be an Immediate release composition comprising between about 0.01 and about 10 mg of naltrexone.

Method for inducing a sustained immune response

A method of preventing and/or controlling convulsions in mammalian patients comprising administering to a patient in need of such treatment a therapeutically effective amount of 3-(3-methyl-2-octyl)-1-[4-(1-homopiperidine) butyryloxy]-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-dibenzo [b,d]pyran hydrochloride.

3-(3-Methyl-2-octyl)-1-[4-(1-ho

Covers 2-substituted-5-alkyl resorcinols represented by the formula ##STR1## wherein R.sub.1 is hydrogen or lower-alkanoyl; R.sub.2 is a straight or branched chain alkyl of 1 to 20 carbon atoms; and X is nitrogen or C-methyl. The compounds of this invention are useful as tranquilizers, analgesics, sedative-hypnotics and anticonvulsants.

Growing community of inventors

Ocean City, NJ, United States of America

Nicholas Plotnikoff